Table 3

Imaging marker progression

Low risk at baseline

High risk at baseline


No progression (%)

With progression (%)

With regression (%)

With progression (%)

No progression (%)

Total number with progression (%)


CAC (n = 142)

103 (72.5)

12 (8.5)

2 (1.4)

21 (14.8)

4 (2.8)

33 (23.2)

AS (n = 106)

67 (63.2)

12 (11.3)

4 (3.8)

23 (21.7)

0

35 (33.0)


Lertratanakul et al. Arthritis Research & Therapy 2012 14(Suppl 3):A21   doi:10.1186/ar3955